- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
MannKind Corp (NNFN)
MannKind Corp stock price live, this page displays NASDAQ MNKD stock exchange data. View the MNKD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the MannKind Corp real time stock price chart below.
What Is the MannKind Corp Stock Price Today?
The MannKind Corp stock price today is 3.48.
What Is the Stock Symbol for MannKind Corp?
The stock symbol for MannKind Corp is ""MNKD.""
What Stock Exchange Does MannKind Corp Trade On?
MannKind Corp is listed and trades on the NASDAQ stock exchange.
Is MannKind Corp a Good Stock to Buy?
Determining whether MannKind Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNKD quote. (ISIN: US56400P7069)
What Is the MannKind Corp Stock Price Today?
The MannKind Corp stock price today is 3.48.
What Is the Stock Symbol for MannKind Corp?
The stock symbol for MannKind Corp is ""MNKD.""
What Stock Exchange Does MannKind Corp Trade On?
MannKind Corp is listed and trades on the NASDAQ stock exchange.
Is MannKind Corp a Good Stock to Buy?
Determining whether MannKind Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MNKD quote. (ISIN: US56400P7069)
3.48
-0.04(-1.14%)
Closed·
Fair Value
An estimate of a MannKind Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.48
3.53
52 wk Range
3.00
7.09
NNFN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a MannKind Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.483.53
52 wk Range
3.007.09
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
NNFN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a MannKind Corp's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Currently not supported.
- MannKind Corp stock hits 52-week low at $3.63
- Investing.com
- MannKind stock hits 52-week low at $3.70
- Investing.com
- Mannkind director Binder sells $296945 in shares
- Investing.com
- Mannkind director Binder sells $296945 in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
MannKind Corp Company Profile
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States. It offers Afrezza Inhalation Powder, an inhaled insulin used to improve glycemic control in adults with diabetes; the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults; and Tyvaso DPI for the treatment of pulmonary arterial hypertension and pulmonary hypertension. The company’s product pipeline includes MNKD-101, a nebulized formulation of clofazimine, which is in Phase 3 study, for the treatment of severe chronic and recurrent pulmonary infections, including nontuberculous mycobacterial lung disease; MNKD-201, a dry-powder formulation of nintedanib, which is in phase 1 clinical study, for the treatment of idiopathic pulmonary fibrosis (IPF); MNKD-301, which is in preclinical stage, for cystic fibrosis; and Pediatric Afrezza, which is in phase 3 clinical trial for the treatment of diabetes mellitus. It has collaboration and license agreement with United Therapeutics Corporation for development, regulatory, and commercial activities of Tyvaso DPI; and collaboration agreement with Thirona to evaluate the therapeutic for the treatment of pulmonary fibrosis. Further, the company has supply and distribution agreement with Biomm S.A. for the commercialization of Afrezza in Brazil; license and distribution agreement with Cipla Ltd. for the marketing and distribution of Afrezza in India; and co-promotion agreement with Amphastar for marketing of Baqsimi (glucagon) nasal powder. MannKind Corporation was incorporated in 1991 and is headquartered in Danbury, Connecticut.
Compare NNFN to Peers and Sector
Metrics to compare | NNFN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNNFNPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.7x | −0.5x | |
PEG Ratio | 0.00 | −0.19 | 0.00 | |
Price/Book | 0.0x | 3.0x | 2.6x | |
Price / LTM Sales | 0.0x | 11.1x | 3.2x | |
Upside (Analyst Target) | 0.0% | 110.3% | 41.4% | |
Fair Value Upside | Unlock | 15.7% | 6.0% | Unlock |
People Also Watch
FAQ
What Stock Exchange Does MannKind Corp Trade On?
MannKind Corp is listed and trades on the Frankfurt Stock Exchange stock exchange.
What Is the Stock Symbol for MannKind Corp?
The stock symbol for MannKind Corp is "NNFN."
What Is the MannKind Corp Market Cap?
As of today, MannKind Corp market cap is 1.05B.
What Is MannKind Corp's Earnings Per Share (TTM)?
The MannKind Corp EPS (TTM) is 0.00.
From a Technical Analysis Perspective, Is NNFN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has MannKind Corp Stock Split?
MannKind Corp has split 0 times.
What is the current trading status of MannKind Corp (NNFN)?
As of 27 Jul 2025, MannKind Corp (NNFN) is trading at a price of 3.48, with a previous close of 3.47. The stock has fluctuated within a day range of 3.48 to 3.53, while its 52-week range spans from 3.00 to 7.09.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.